Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Lowered to $106 at Leerink Partners

April 21, 2026 4:15 AM
Leerink Partners analyst Mike Kratky lowered the price target on Abbott Labs (NYSE: ABT) to $106.00 (from $119.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change